National Health (NHI) | Financial Analysis & Statements
National Health Investors, Inc. Mid-cap Real Estate
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
105.8M
Gross Profit
103.3M
97.57%
Operating Income
50.2M
47.47%
Net Income
37.8M
35.72%
EPS (Diluted)
$0.80
Balance Sheet Metrics
Total Assets
2.8B
Total Liabilities
1.3B
Shareholders Equity
1.5B
Debt to Equity
0.82
Cash Flow Metrics
Operating Cash Flow
69.4M
Free Cash Flow
67.7M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
National Health Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 375.6M | 335.2M | 319.8M | 278.2M | 298.7M |
| Cost of Goods Sold | 11.0M | 11.2M | 11.5M | 9.8M | 11.6M |
| Gross Profit | 364.6M | 324.0M | 308.3M | 268.4M | 287.1M |
| Gross Margin % | 97.1% | 96.7% | 96.4% | 96.5% | 96.1% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 29.5M | 21.8M | 19.8M | 25.3M | 19.3M |
| Other Operating Expenses | 62.5M | 42.3M | 39.6M | 28.2M | - |
| Total Operating Expenses | 92.0M | 64.0M | 59.4M | 53.5M | 19.3M |
| Operating Income | 190.6M | 183.9M | 178.8M | 132.8M | 185.3M |
| Operating Margin % | 50.7% | 54.9% | 55.9% | 47.7% | 62.0% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 53.9M | 56.1M | 55.5M | 42.4M | 48.1M |
| Other Non-Operating Income | 7.6M | 12.6M | 13.8M | -22.4M | -22.4M |
| Pre-tax Income | 140.8M | 136.6M | 134.5M | 65.4M | 112.0M |
| Income Tax | - | - | - | - | - |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Income | 140.8M | 136.6M | 134.4M | 65.5M | 112.0M |
| Net Margin % | 37.5% | 40.8% | 42.0% | 23.5% | 37.5% |
| Key Metrics | |||||
| EBITDA | 275.2M | 251.9M | 246.9M | 202.9M | 262.2M |
| EPS (Basic) | $3.03 | $3.14 | $3.13 | $1.48 | $2.45 |
| EPS (Diluted) | $3.02 | $3.13 | $3.13 | $1.48 | $2.44 |
| Basic Shares Outstanding | 46874691 | 43844771 | 43388794 | 44774708 | 45714221 |
| Diluted Shares Outstanding | 46874691 | 43844771 | 43388794 | 44774708 | 45714221 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
National Health Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 19.6M | 24.3M | 22.3M | 19.3M | 37.4M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 85.5M | 93.6M | 89.6M | 81.9M | 99.4M |
| Inventory | - | - | - | - | - |
| Other Current Assets | - | - | - | - | - |
| Total Current Assets | 316.9M | 396.9M | 375.2M | 383.0M | 514.8M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | - | - | - | - | - |
| Goodwill | - | - | - | - | - |
| Intangible Assets | - | - | - | - | - |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 6.2M | 6.2M | 16.9M | 9.4M | 15.8M |
| Total Non-Current Assets | 2.5B | 2.2B | 2.1B | 2.1B | 2.3B |
| Total Assets | 2.8B | 2.6B | 2.5B | 2.5B | 2.8B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 43.7M | 37.8M | 34.3M | 25.9M | 23.2M |
| Short-term Debt | 204.0M | 331.2M | 245.0M | 42.0M | - |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | - | - |
| Total Current Liabilities | 297.2M | 414.4M | 324.4M | 112.0M | 70.2M |
| Non-Current Liabilities | |||||
| Long-term Debt | 959.8M | 814.8M | 890.1M | 1.1B | 1.2B |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | - | - | - | - | 8.8M |
| Total Non-Current Liabilities | 959.8M | 814.8M | 890.1M | 1.1B | 1.3B |
| Total Liabilities | 1.3B | 1.2B | 1.2B | 1.2B | 1.3B |
| Equity | |||||
| Common Stock | 483.0K | 457.0K | 434.0K | 434.0K | 459.0K |
| Retained Earnings | 2.7B | 2.6B | 2.5B | 2.3B | -84.6M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 1.5B | 1.4B | 1.3B | 1.3B | 1.5B |
| Key Metrics | |||||
| Total Debt | 1.2B | 1.1B | 1.1B | 1.1B | 1.2B |
| Working Capital | 19.8M | -17.4M | 50.8M | 271.0M | 444.6M |
Balance Sheet Composition
National Health Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 140.8M | 136.6M | 134.4M | 65.5M | 112.0M |
| Depreciation & Amortization | 80.9M | 71.4M | 70.0M | 70.9M | 80.8M |
| Stock-Based Compensation | 5.6M | 4.2M | 4.6M | 8.6M | 8.4M |
| Working Capital Changes | 7.3M | -2.6M | 3.3M | -6.2M | -4.5M |
| Operating Cash Flow | 240.7M | 221.1M | 199.7M | 211.7M | 235.8M |
| Investing Activities | |||||
| Capital Expenditures | - | -4.1M | -3.7M | 0 | -64.0K |
| Acquisitions | - | - | - | 0 | 0 |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | 21.2M | -45.0M | -25.9M | 39.4M | -4.5M |
| Financing Activities | |||||
| Share Repurchases | - | 0 | 0 | -152.0M | 0 |
| Dividends Paid | -169.7M | -156.5M | -156.2M | -161.8M | -182.9M |
| Debt Issuance | 1.0B | 449.7M | 564.0M | 225.0M | 491.8M |
| Debt Repayment | -1.0B | -438.9M | -576.4M | -318.4M | -752.4M |
| Financing Cash Flow | 25.7M | -13.6M | -169.7M | -401.3M | -701.0M |
| Free Cash Flow | 236.6M | 203.7M | 180.7M | 185.3M | 210.8M |
| Net Change in Cash | 287.6M | 162.5M | 4.0M | -150.2M | -469.7M |
Cash Flow Trend
National Health Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
27.60
Forward P/E
22.96
Price to Book
2.65
Price to Sales
10.65
PEG Ratio
-1.66
Profitability Ratios
Profit Margin
37.49%
Operating Margin
61.34%
Return on Equity
9.63%
Return on Assets
4.52%
Financial Health
Current Ratio
0.54
Debt to Equity
97.57
Beta
0.66
Per Share Data
EPS (TTM)
$3.02
Book Value per Share
$31.50
Revenue per Share
$8.09
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| NHI | 3.8B | 27.60 | 2.65 | 9.63% | 37.49% | 97.57 |
| Welltower | 147.1B | 146.65 | 3.44 | 2.54% | 8.64% | 49.49 |
| Ventas | 39.8B | 153.57 | 3.14 | 2.17% | 4.32% | 102.00 |
| American Healthcare | 9.6B | 119.29 | 2.80 | 2.50% | 3.09% | 50.20 |
| CareTrust REIT | 8.5B | 23.76 | 2.06 | 9.17% | 67.28% | 71.95 |
| Healthcare Realty | 6.6B | 39.90 | 1.39 | -5.00% | -20.85% | 88.77 |
Financial data is updated regularly. All figures are in the company's reporting currency.






